斑马鱼纤维蛋白原缺失导致无症状胚胎期止血缺陷并与血小板减少症协同致死
研究利用TALEN基因组编辑技术构建斑马鱼fga突变体,发现其从出生后3天起即存在严重止血缺陷但无可见出血,静脉内皮损伤后血栓形成完全缺失,该缺陷可被野生型fga cDNA质粒或纯化人纤维蛋白原显微注射恢复;fga缺失与血小板减少症组合导致协同致死,并用于鉴定人类FGA意义不明变异的致病性。
要点
- 斑马鱼fga突变体在出生后3天即出现严重止血缺陷,但无可见出血。
- fga缺失与血小板减少症组合导致协同致死。
- 静脉内皮损伤后突变体胚胎和幼鱼血栓形成完全缺失。
核心结论
- 斑马鱼纤维蛋白原缺失导致从胚胎期至成年期止血功能缺失。
- fga缺失与血小板减少症组合在斑马鱼中表现为协同致死。
研究设计与样本
- 研究采用TALEN基因组编辑技术构建斑马鱼fga突变体。
- 通过生存分析、大体解剖与组织学观察及激光诱导内皮损伤评估止血缺陷。
- 将人类FGA意义不明变异工程化至斑马鱼fga同源位点以评估致病性。
主要发现
- 斑马鱼fga突变体在出生后3天即存在严重止血缺陷,但无可见出血。
- 突变体胚胎和幼鱼经静脉内皮损伤诱导的血栓形成完全缺失。
- 显微注射野生型fga cDNA质粒或纯化人纤维蛋白原可恢复该止血缺陷。
- fga缺失与血小板减少症组合导致协同致死。
关键数值与推荐
- 斑马鱼fga突变体出生后3天即存在严重止血缺陷,但无可见出血。
- 静脉内皮损伤诱导的血栓形成在突变体胚胎和幼鱼中完全缺失。
- 显微注射野生型fga cDNA质粒或纯化人纤维蛋白原可恢复止血缺陷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials Loss of fibrinogen in zebrafish has been previously shown to result in adult onset hemorrhage Hemostatic defects were discovered in early fga-/- embryos but well tolerated until adulthood Afibrinogenemia and thrombocytopenia results in synthetic lethality in zebrafish. Testing human FGA variants of uncertain significance in zebrafish identified causative mutations SUMMARY: Background Mutations in the alpha chain of fibrinogen (FGA), such as deficiencies in other fibrinogen subunits, lead to rare inherited autosomal recessive hemostatic disorders. These range from asymptomatic to catastrophic life-threatening bleeds and the molecular basis of inherited fibrinogen deficiencies is only partially understood. Zinc finger nucleases have been used to produce mutations in zebrafish fga, resulting in overt adult-onset hemorrhage and reduced survival. Objectives To determine the age of onset of hemostatic defects in afibrinogenemic zebrafish and model human fibrinogen deficiencies. Methods TALEN genome editing (transcription activator-like effector nucleases) was used to generate a zebrafish fga mutant. Hemostatic defects were assessed through survival, gross anatomical and histological observation and laser-induced endothelial injury. Human FGA variants with unknown pathologies were engineered into the orthologous positions in zebrafish fga. Results Loss of Fga decreased survival and resulted in synthetic lethality when combined with thrombocytopenia. Zebrafish fga mutants exhibit a severe hemostatic defect by 3 days of life, but without visible hemorrhage. Induced thrombus formation through venous endothelial injury was completely absent in mutant embryos and larvae. This hemostatic defect was restored by microinjection of wild-type fga cDNA plasmid or purified human fibrinogen. This system was used to determine whether unknown human variants were pathological by engineering them into fga. Conclusions These studies confirm that loss of fibrinogen in zebrafish results in the absence of hemostasis from the embryonic period through adulthood. When combined with thrombocytopenia, zebrafish exhibit synthetic lethality, demonstrating that thrombocytes are necessary for survival in response to hemorrhage.
引用
- Hu Z, Lavik KI, Liu Y, et al. Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia. J Thromb Haemost. 2019. PMID: 30663848. doi:10.1111/jth.14391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。